Clinical trial
Fluoxetine as a Quit Smoking AID for Depression Prone
NCT00113737 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00113737 |
|---|---|
| Title | Fluoxetine as a Quit Smoking AID for Depression Prone |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Cardiovascular Diseases, Heart Diseases |
| Intervention type | Behavioral, Drug |
| Interventions | fluoxetine, cognitive behavioral therapy |
| Start date | Feb 1, 1998 |
| Completion | Jan 1, 2002 |
| First posted | Jun 10, 2005 |
| Last update posted | Feb 18, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: